Cargando…
Nanoparticle pre-treatment for enhancing the survival and activation of pulmonary macrophage transplant
Despite recent clinical successes of chimeric antigen receptor T cell therapies in treating liquid cancers, many lingering challenges stand in the way of therapeutic translation to broader types of malignancies. Macrophages have been proposed as alternatives to T cells given macrophages’ advantages...
Autores principales: | Jarai, Bader M., Bomb, Kartik, Fromen, Catherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238309/ https://www.ncbi.nlm.nih.gov/pubmed/36917409 http://dx.doi.org/10.1007/s13346-023-01319-6 |
Ejemplares similares
-
Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants
por: Stillman, Zachary S., et al.
Publicado: (2023) -
Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
por: Lundgren, Scott W., et al.
Publicado: (2021) -
Pulmonary Macrophage Transplantation Therapy
por: Suzuki, Takuji, et al.
Publicado: (2014) -
Engineering Preclinical Tools and Therapeutics to Understand and Treat COVID-19
por: Fromen, Catherine A., et al.
Publicado: (2020) -
Deformable microparticles for shuttling nanoparticles to the vascular wall
por: Fish, Margaret B., et al.
Publicado: (2021)